The global prefilled syringes market size was valued at USD 17.16 billion in 2023 and is expected to hit around USD 46.09 billion by 2032 poised to grow at a CAGR of 11.6% during the forecast period 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
The Europe prefilled syringes market size was valued at USD 6.85 billion in 2023 and is expected to reach USD 18.11 billion by 2032, growing at a CAGR of 11.40% from 2023 to 2032.
Europe is one of the major profit-generating regions in the prefilled syringes market. Rising frequency of chronic conditions, technological advancements, growth of the biologics and biosimilars market, geographical expansion by crucial manufacturers, growing population, and high adoption of tone-injection bias are driving the demand for tone-injectable prefilled syringes are the major factors driving the growth of the prefilled syringes market in Europe.
A pre-filled syringe is also recognized as a package which is comprised of single-dose of medicine in which an attached needle also provided by the manufacturer. Previously, metal or glass syringes were very common in the industry of industry, but slowly & steadily consumer shift have been observed more towards disposable or plastic syringes in order to secure the needle and make it use and throw so that it cannot be re-utilized. In addition, this has revitalized the demand towards safe and convenient pre-filled syringes in the pharmaceutical market over conventional glass vials for storing drugs.
The impact of the driving factors is anticipated to surpass the effect of restraints. Also, the technological advancements leading to advanced adoption rate and untapped markets in the developing countries are anticipated to give new avenues for the growth of market in the near future. Likewise, growing use of technological advancements and prefilled syringes in auto-injectors are the crucial factors propelling the market. Furthermore, prefilled syringes are fleetly swapping traditional combinations of syringe-vial owing to advantages provided by them, similar as convenience for healthcare practitioners and increased patient safety in cure medication and delivery.
These syringes enable easy operation of chronic diseases, similar as rheumatoid arthritis, and diabetes which is anticipated to boost the use of auto-injectors and pen injectors during the forecast period. Therefore, the growing frequency of chronic disease like diabetes and other diseases is likely to fuel the market demand over the upcoming time period. In addition, the launch of advanced equipment with Wi-Fi and Bluetooth connectivity easing effective operation of patient health records is also anticipated to boost the product demand.
| Report Coverage | Details |
| Market Size by 2023 | USD 17.16 Billion |
| Market Size by 2032 | USD 46.09 Billion |
| Growth Rate from 2023 to 2032 |
CAGR of 11.6% |
| Base Year | 2022 |
| Largest Market | Europe |
| Fastest Growing Market | North America |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Type, Material, Design, Product, Closing System, Application, End User, Region |
| Companies Mentioned | SCHOTT AG, West Pharmaceutical Services, Inc., Baxter International Inc., Weigao Group, Vetter Pharma International GmbH, Nipro Corporation, Elcam Medical, Oval Medical Technologies, SHL Medical AG, Terumo |
In addition, the usage of pre-filled syringe has skyrocketed owing to the numerous difficulties in the traditional process. There are various advantages pre-filled syringes have in place of traditional packaging in vials which comprise of ease in use. As prefilled syringes efficiently mitigate the processes which is further required before using any drug in a vial. Moreover, it further helps in removing errors while providing doses to the patient’s as prefilled syringes are importantly comprise of the exact dose required for the patient. In addition, numerous producers of pharmaceuticals overfill their vials by up to 18%, however, this overfilled of vials is likely to cause many errors while giving a dose to the patient which can easily be mitigated with the help of the pre-filled syringes. Also, there exists excessive syringes development and various new products have been launched and are being kept in syringes now for the microbial safety. Pre-filled syringes are used in the packaging of injectable and diluents drugs. Some of the majorly listed drugs packaged in pre-filled syringes includes vaccines, blood stimulants, ervthroproteins, therapeutic proteins, and rheumatoid arthritis. Thus, comfort in utilization and better safety of the drug is the major factor which is leading to rise in demand for prefilled syringes in the market.
The impact of the COVID-19 on the market is likely to be more varied owing to the upsurge manufacturing of vaccines. In addition, growing demand for similar syringes instead of glass ampoules or other alternate needles have been observed on account of the decreased trouble of needle injuries. Accordingly, in order to boost the production of the COVID-19 vaccination, the producers are increasing their manufacturing capability.
The demand for prefilled syringes has risen due to the COVID-19 pandemic. The surge in number of COVID-19 patients is paving new ways for the growth of the global prefilled syringes market during 2020. Another factor boosting the growth of the global prefilled syringes market is growing incidences of rheumatoid arthritis and diabetes all over the world. In addition, the growing concerns about the safety of injectables are propelling the prefilled syringes market. The growing technological developments in the prefilled syringes market are also driving the demand for prefilled syringes. The prefilled syringes are widely adopted in the developed and developing regions such as North America and Europe. Moreover, the surge in demand for biosimilars is also contributing to the growth of the prefilled syringes market.
On the basis of type, safety prefilled syringes segment is likely to foresee the loftiest growth during the forthcoming time period majorly owing to the growing senior population worldwide and biological therapies availabilities for patients with suffering from chronic diseases and low- threat medical procedures outsourcing for chronic patients ease some of the pressure on hospitals.
The glass prefilled syringes segment reckoned for the largest share of the prefilled syringes in 2022. The large share of this segment is attributed to the significant benefits offered, similar as forestallment of oxygen and water vapor from interacting with medicine composites, comity with different stuffing machines, and flawless integration into pharmaceutical companies PFS operations.
The single- chamber prefilled syringes segment reckoned for the largest share of the prefilled syringes market. Furthermore, the market growth is majorly attributed to the significant benefits with the usage of prefilled syringes of single-chamber over vials, similar as optimized API use with lower overfill, lower medicine waste in clinical trials, reduced material requirements, and simple storage& disposal. Also, upsurge in self-administered parenteral medicines adoption owing to the adding frequency of various chronic diseases and advantages offered by them.
Segments Covered in the Report
By Type
By Material
By Design
By Product
By Application
By Closing System
By End User
By Geography
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
